Eurofins Scientific
€74.86Change from previous close: +0.43%Absolute change: +€0.32
At a glance
- Revenue growth
- +4.96%
- 2025 vs 2024
- Net income growth
- +16.83%
- 2025 vs 2024
- Net margin
- 6.5%
- 2024: 5.8%
Financial data
Amounts in millions of EUR; per-share values in EUR; shares in millions.
| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Total revenue | 7,296 | 6,951 | 6,515 | 6,712 | — |
| Cost of revenue | 2,326 | 2,239 | 2,151 | 2,227 | — |
| Gross profit | 4,970 | 4,712 | 4,364 | 4,485 | — |
| Operating income | 818 | 726 | 547 | 783 | — |
| EBIT | 811 | 705 | 553 | 886 | — |
| EBITDA | 1,534 | 1,397 | 1,217 | 1,495 | — |
| Interest expense | 157 | 151 | 129 | 106 | — |
| Pre-tax income | 654 | 555 | 423 | 780 | — |
| Income tax | 181 | 149 | 116 | 174 | — |
| Net income | 475 | 406 | 310 | 610 | — |
| Net income to common shareholders | 475 | 406 | 310 | 610 | — |
| Basic EPS | 2.64 | 2.13 | 1.61 | 3.17 | — |
| Diluted EPS | 2.55 | 2.09 | 1.57 | 3.07 | — |
| Average shares (basic) | 180 | 191 | 193 | 193 | — |
| Average shares (diluted) | 187 | 195 | 198 | 199 | — |